SMAD2 and non-small cell lung carcinoma: Upon TGF-β1 treatment, the levels of p-Smad2 and p-Smad3 increased in NSCLC cells while this trend was reversed by circ6834 overexpression (Fig. 3L and Supplementary Fig. 5G).